RxDoctor Payments Data

Amy Broach, MD

Obstetrics & Gynecology · Durham, NCNPI 1760692313

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $23,950 of the $27,322 with a category attached, or 87.7%. Covidien LP accounts for 79.5% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2020 at $11,000 and has fallen 78.9% since, to $2,319 in 2025. Among obstetrics & gynecology clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$27,322in general payments, 2019–2025

Across 30 payments — averaging $910.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Covidien LP$22K
  • Medtronic$5K
  • Johnson & Johnson$121
  • Acessa Health Inc.$96
  • Myovant Sciences Inc.$35
  • Cordis US CORP.$29

What the payments were for

  • Consulting fees$2,2508%
  • Speaking & faculty fees$23,95088%
  • Travel & lodging$5032%
  • Food & beverage$6192%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$27,322 in reported general payments places this provider in the 95th percentile of 1,344 obstetrics & gynecology providers in North Carolina.

See all obstetrics & gynecology providers in North Carolina

Medicare billing

Part B allowed, 2024
$17,278
Medicare patients
111
Services billed
201

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
YuvafemEstradiol14$1,696
Estradiol34$1,373
Norethindrone Acetate13$319

Paid to pharmacies, not to this prescriber.

Other obstetrics & gynecology in Durham

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →